Novavax (NVAX) Change in Receivables (2010 - 2016)
Novavax (NVAX) posted quarterly Change in Receivables of -$1.7 million for Q3 2016, down 243.2% year-over-year from $1.2 million in Q4 2015, and down 6500.0% quarter-over-quarter from -$26000.0 in Q2 2016.
Novavax (NVAX) Change in Receivables (2010 - 2016) Analysis & Trends
Novavax's Change in Receivables history runs 7 years deep, the most recent figure standing at -$1.7 million for Q3 2016.
- In Q3 2016, Change in Receivables fell 243.2% year-over-year to -$1.7 million; the TTM figure through Sep 2016 stood at -$5.7 million (down 55.73% YoY), while the FY2016 annual figure was -$2.1 million, up 75.56% from the prior year.
- Change in Receivables for Q3 2016 stood at -$1.7 million, down from -$26000.0 in the prior quarter.
- The five-year high for Change in Receivables was $2.8 million in Q4 2014, with the low at -$6.0 million in Q2 2015.
- The 5-year median for Change in Receivables is -$240000.0 (2012), against an average of -$464894.7.
- The sharpest annual moves came in 2014 and 2016: Change in Receivables jumped 1661.25% in 2014, then plunged 2569.23% in 2016.
- Novavax's Change in Receivables stood at -$1.5 million in 2012, then jumped by 110.97% to $160000.0 in 2013, then surged by 1661.25% to $2.8 million in 2014, then sank by 171.43% to -$2.0 million in 2015, then rose by 14.75% to -$1.7 million in 2016.
- Business Quant data shows NVAX's Change in Receivables at -$1.7 million in Q3 2016, -$26000.0 in Q2 2016, and -$1.9 million in Q1 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 117.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -483,662.49 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 31.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 37.16 Mn |
| 10 | Novavax | 1.33 Bn | 607.37 Mn | 42.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | -1.72 Mn |
| Sep 30, 2016 | -1.72 Mn |
| Jun 30, 2016 | -26,000.00 |
| Jun 30, 2016 | -26,000.00 |
| Mar 31, 2016 | -1.93 Mn |
| Mar 31, 2016 | -1.93 Mn |
| Dec 31, 2015 | -2.01 Mn |
| Dec 31, 2015 | -2.01 Mn |
| Sep 30, 2015 | -500,000.00 |
| Sep 30, 2015 | -500,000.00 |
| Jun 30, 2015 | -6.04 Mn |
| Jun 30, 2015 | -6.04 Mn |
| Mar 31, 2015 | 78,000.00 |
| Mar 31, 2015 | 78,000.00 |
| Dec 31, 2014 | 2.82 Mn |
| Dec 31, 2014 | 2.82 Mn |
| Sep 30, 2014 | -829,000.00 |
| Sep 30, 2014 | -829,000.00 |
| Jun 30, 2014 | -731,000.00 |
| Jun 30, 2014 | -731,000.00 |